Tag Archives: WHO

Industry, Patents and Public Health: Wimps on the Barbie?

The welcome news of a compact between industry and the WHO to fight neglected diseases in the developing world only highlights a much more spotty industry record of engagement on sensitive policy issues like intellectual property rights. One of the industry’s more ambitious policy-driven efforts occurred some five years ago with a strong, well-funded and […]
Posted in Corporate Responsibility, Global, Legal, R&D, Strategy | Also tagged , , , | 1 Comment

WHO Brings Big Pharma Together to Fight Debilitating Diseases

A new report from WHO on overcoming the impact of neglected tropical diseases has spawned a $150 million funding and donation initiative from Big Pharma. Last week, the World Health Organization (WHO) announced an initiative involving six Pharmaceutical companies—Novartis, GlaxoSmithKline, Sanofi-Aventis, Johnson & Johnson, Bayer, and Eisai of Japan—that will bring much-needed funding and research […]
Posted in Deals, Global, R&D | Tagged | 1 Comment

WHO Threatens Industry Shut-out on Counterfeit Regulation

Big Pharma believes that a global generics franchise might give it a softer landing off the patent cliff, but governments that sponsor and regulate the industry are still acting a bit slow on the uptake. The reason? Anti-IP activists are again poisoning the well on global access to medicines, engaging the bigger emerging market governments […]
Posted in Global | Also tagged , , , , , | Leave a comment

WHO Pushes H1N1 Flu to Pandemic State

Image by Quiplash! via Flickr The Word Health Organization just bumped the H1N1 influenza to pandemic alert phase 6 (the highest alert level), making it the first worldwide pandemic in 41 years. According to WHO Director-General Margaret Chan, 30,000 cases of the swine flu have been reported in 74 countries, but there is a very […]
Posted in Manufacturing, Safety | Also tagged , , , , , , , , | 1 Comment
  • Categories

  • Meta